Navigation Links
Cumberland Pharmaceuticals Reports Second Quarter 2009 Financial Results
Date:8/27/2009

Total current assets 17,710,198 19,911,212 Property and equipment, net 432,413 505,174 Intangible assets, net 8,528,732 8,226,047 Deferred tax assets 1,000,031 1,000,031 Other assets 3,447,813 3,705,275 --------- --------- Total assets $31,119,187 $33,347,739 LIABILITIES AND EQUITY Current liabilities: Current portion of long-term debt $1,250,000 $1,666,667 Current portion of other long-term obligations 457,915 1,263,491 Accounts payable 3,257,164 2,420,175 Other accrued liabilities 2,640,855 2,586,396 --------- --------- Total current liabilities 7,605,934 7,936,729 Revolving line of credit 1,825,951 1,825,951 Long-term debt, excluding current portion 3,750,000 2,916,666 Other long-term obligations, excluding current portion 382,487 159,165 ------- ------- Total liabilities 13,564,372 12,838,511 ---------- ---------- Commitments and contingencies Redeemable common stock - 630,000 Shareholders' equity: Cumberland Pharmaceuticals Inc. shareholders' equity: Convertible preferred stock - no par value; 3,000,000 shares authorized; 812,
'/>"/>
SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Orion ICG, LLC Announces Acquisition of Cumberland Therapy Services, Inc.
2. Cumberland Pharmaceuticals Announces Appointments
3. Cumberland Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 27, 2009
4. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
5. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
6. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
7. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
9. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
10. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
11. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2015)... In the United States alone, an ... treatment for an illicit drug or alcohol ... Mental Health Services Administration’s Survey on Drug Use and ... are harrowing stories of men and women whose lives ... David H. Kerr , founder and retired president of ...
(Date:4/25/2015)... (PRWEB) April 25, 2015 By definition, a ... data for the enterprise relying on their judgement and expertise ... But according to an article published in National ... times actually be doing a disservice to their responsibilities by ... dotted and t’s are crossed when it comes to company ...
(Date:4/25/2015)... Bradley, Illinois (PRWEB) April 25, 2015 ... life enrichment and wellness, management and operations, and ... Annual Meeting and Exhibition scheduled to be held ... Illinois. , LeadingAge Illinois is the largest eldercare ... leading providers of services for older adults, including ...
(Date:4/25/2015)... April 25, 2015 Sports controversies continue to revolve ... confines, as was the case with the Miami Dolphins and Richie ... seen in the Ray Rice domestic abuse case. In a recent ... News discusses the implications of locker room culture on teams. ... what other teams should do to improve the locker room as ...
(Date:4/24/2015)... April 24, 2015 Bird B Gone, the ... applications now offers a complete line of bird control solutions ... farms. , New Flu Strains Threaten Pacific, Central and Mississippi ... post , a number of highly pathogenic avian flus ... disease is often spread when wild birds enter poultry farms. ...
Breaking Medicine News(10 mins):Health News:New Book Features Powerful Stories of People Who Overcame Addiction 2Health News:New Book Features Powerful Stories of People Who Overcame Addiction 3Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 2Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 3Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 4Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 5Health News:Gardant Management Solutions Staff Shares Operational Expertise 2Health News:David Steele Discusses Locker Room Culture on SCI TV 2Health News:David Steele Discusses Locker Room Culture on SCI TV 3Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 2Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 3Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 4
... $1 million worth unpaid bills pending at the Waikato hospital ... those patients who use the taxpayer-funded health care facilities to ... citizens of New Zealand nor do they hold a valid ... which are meant only for the tax paying citizens. ...
... (NZFSA) has issued a warning to the Kiwi parents to ... has additives not cleared for use in New Zealand . ... baby food in the country. ,The NZFSA raised concern ... formula. ,Four Nutricia Karicare Gold Plus products produced by ...
... and the Indian government, impoverished women in Orissa are battling ... ,Known as Positive Deviance, the programme is being ... child welfare and the department of social welfare in the ... in the tribal areas of Orissa. It is particularly severe ...
... State Government has picked around 1,065 illegal health institutions found ... will be moving in to arrest and prosecute ... wipe out sub-standard hospitals, clinics and chemist shops which ... had last week sealed up 235 illegal health facilities in ...
... The British government has provided a fund of 500, 000 ... . ,The joint project between the environment department ... new materials based on plant fibres to replace metal and ... Qinetiq have already designed hemp replacements for the accelerator, brake ...
... There has been an alarming rise in the number of ... Kashmir way back in 1989 . Unfortunately, most such incidents ... there were 736 cases of attempted suicide from 2001 until ... be quite different. ,,The records of just one major ...
Cached Medicine News:Health News:$1 Million Unpaid Bills by Health Care Cheats at Waikato Hospital 2Health News:Additives in Baby Products Raise Fresh Concerns in New Zealand 2Health News:Feeding Programme Gives Hope to Tribal Mothers 2Health News:Nigerian Health Authority Crackdown On Sub-Standard Health Institutions 2Health News:Kashmir Battles Alarming Increase in Suicides 2Health News:Kashmir Battles Alarming Increase in Suicides 3
(Date:4/23/2015)...  AbbVie (NYSE: ABBV ) has announced that ... its New Drug Application (NDA) and granted priority review ... of ombitasvir, paritaprevir, ritonavir (OBV/PTV/r), with ribavirin (RBV). The ... genotype 4 (GT4) hepatitis C virus (HCV) infection. ... being evaluated by the FDA for patients in ...
(Date:4/23/2015)... , April 23, 2015 Once again, ... strengthening our commitment to patient safety. BeaconMedaes, ... fight against infectious disease. The next generation ... Medical gas sensors are now mounted in the assembly, ... need to open ceiling tiles potentially releasing dust spores ...
(Date:4/23/2015)... FRANCISCO , April 23, 2015 Nektar Therapeutics ... the first quarter ended March 31, 2015 on Thursday, April ... Howard Robin , president and chief executive officer, will host ... p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT). ... the conference call can be accessed through a link that ...
Breaking Medicine Technology:U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 3U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 4U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 5U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 6U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 7BeaconMedaes launches new Zone Valve Box Assembly 2Nektar to Announce Financial Results for the First Quarter 2015 on Thursday, April 30, 2015, After Close of U.S.-Based Financial Markets 2
... Photocure (OSE: PHO), a Norwegian specialty pharmaceutical company ... from its consumer trial with Allumera™, a breakthrough cosmetic ... The RevitAll study was performed with a standard ... Allumera™ improves skin appearance, when compared to exposure by ...
... Inc. (Hologic or the Company) (Nasdaq: ... of premium diagnostics products, medical imaging systems and ... of women, announced today the U.S. Food and ... Makena™ (hydroxyprogesterone caproate injection), formerly known as Gestiva™. ...
Cached Medicine Technology:Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements 2Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements 3Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements 4FDA Approves Hologic's Makena™ (Formerly Referred to as Gestiva™) Pharmaceutical 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: